Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Transition Metal Catalyzed Cyanation. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN102358715B details a low-toxicity cyanation method using potassium ferrocyanide, offering significant cost reduction and safety advantages for pharmaceutical intermediate manufacturing.